26.17 -1.25 (-4.50%)
AMAG
Stock Details
Last Trade:26.17 Change:-1.25 (-4.50%) Prev Close:27.42 Open: 27.76 Days Range:24.62 – 28.95 52 Week Range: 18.33 - 66.94 Volume:922879 P/E: N/AEPS:-3.52
View AllRecent Alerts 11/21/08
Recent Alert on 11/13/08 at 12:53pm
Unusual 11 Mid-Day Movers 11/13: AMAG, OPTR, CBG, GSOL Higher; WCG, CROX, FEED, PERY Lower
Unusual 11 Mid-Day Movers 11/13: AMAG, OPTR, CBG, GSOL Higher; WCG, CROX, FEED, PERY Lower
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) 90.3% HIGHER; announced that the U.S. FDA has designated the Company's resubmission to the October 2008 Complete Response letter for its New Drug Application for ferumoxytol as a complete, Class 1 response.... Read More
Recent Alert on 11/13/08 at 9:27am
Morning Movers 11/13: WellCare Health (WCG) Lower on 10-Q Delay, Intel's (INTC) Warning Hurts Tech
Morning Movers 11/13: WellCare Health (WCG) Lower on 10-Q Delay, Intel's (INTC) Warning Hurts Tech
Recent Alert on 11/13/08 at 9:07am
FDA Designates NDA for AMAG Pharma's (AMAG) Ferumoxytol as Complete; FDA Sets Dec. 30 PDUFA Date
FDA Designates NDA for AMAG Pharma's (AMAG) Ferumoxytol as Complete; FDA Sets Dec. 30 PDUFA Date
Recent Alert on 11/13/08 at 9:07am
FDA Designates NDA for AMAG Pharma's (AMAG) Ferumoxytol as Complete; FDA Sets Dec. 30 PDUFA Date
FDA Designates NDA for AMAG Pharma's (AMAG) Ferumoxytol as Complete; FDA Sets Dec. 30 PDUFA Date
Recent Alert on 11/13/08 at 8:34am
AMAG Pharmaceuticals (AMAG) Announces Ferumoxytol Resubmission Designated Complete, Class 1 Response by the FDA
AMAG Pharmaceuticals (AMAG) Announces Ferumoxytol Resubmission Designated Complete, Class 1 Response by the FDA
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/21/08 at 4:22pm
Analyst upgrades, downgrades and initiations: KR, CCE, WFMI, TWC, ANN ...
Analyst upgrades, downgrades and initiations: KR, CCE, WFMI, TWC, ANN ...
Blog Posts on 10/08/08 at 7:43am
Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)
Top Pre-Market Analyst Upgrades (AMAG, ANDE, BAC, BMC, CDNS, CTXS, IPAR, JEF, MDR, MYGN, NUVA, SYMC)